I care S
Natural health product licensed in Canada
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80068264
- Status
- Inactive licence
- Licence date
- 5 April 2016
- Revision date
- 17 March 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 250 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine E: up to 90 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 40 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 40 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 250 milligramme | 250,000 µg |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 90 milligramme | 90,000 µg |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 200 UI | Not calculated |
| Cuivre Source : Produit de chélation de cuivre (II) et de protéine végétale hydrolysée (PVH) | 1 milligramme | 1,000 µg |
| Lutéine Source : Lutéine | 3 milligramme | Not calculated |
| Zinc Source : Gluconate de zinc | 40 milligramme | 40,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Manioc, Dioxyde de silicium, Oxyde de fer (Fe2O3), Gélatine, Hypromellose, Cellulose microcristalline, Acide stéarique, Oxyde de Fer Jaune, Oxyde de fer noir, Dioxyde de titane, Sucrose, Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Supplément multivitaminé/minéral. Contribue au maintien d'une bonne santé. Aide au développement et au maintien des os et des dents. Aide au développement et au maintien des os, du cartilage, des dents et des gencives. Fournit des antioxydants pour le maintien d'une bonne santé. Antioxydant pour le maintien de la santé oculaire. Aide à préserver la vision dans certaines conditions (associées au dommage par le soleil) Telles que les cataractes et la dégénérescence maculaire reliée à l'âge. Aide à réduire le risque de développer des cataractes. Aide à améliorer la densité optique du pigment maculaire.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Garder hors de portée des enfants.
Source
Official Health Canada record, licence 80068264
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging